MATCHSTICKTECHNOLOGIES - Key Persons
Independent Director: John Fluke, Jr. (Chairman, Fluke Capital Management, LP) provides Matchstick Technologies with extensive corporate governance expertise focused on successful commercialization of emerging companies' technologies.
(Chairman, Fluke Capital Management, LP) provides Matchstick Technologies with extensive corporate governance expertise focused on successful commercialization of emerging companies' technologies.
His current and previous board member experiences include: Athira Pharma, Inc. (2014-present NASDAQ); MatchStick Technologies, Inc. (2015-present - Private); ReelSONAR, Inc. (Private); Pluristyx, Inc. (Private); Precision Genome Engineering (2010-2014 - acquired by Bluebird Biotechnology, Inc. NASDAQ: BLUE); Reedholm Systems Corporation (2015-present - Private:); PACCAR Inc (NASDAQ: PCAR) Fluke Corp. - CEO 1983-1989, chairman 1984-1990 and director 1983-1998 (NYSE: FLK acquired by Danaher Inc. 1998 NYSE: DHR - spunout as Fortive Inc. 2015-preent NYSE: FTV); PRIMUS International (2002-2005 - PCP Berkshire Hathaway); American Seafoods Group, LLC (2001-2006 Private); Cell Therapeutics Inc. (2002-2005 NASDAQ: CTIC)
Job Titles:
- Chairman of the Board
- Washington Researchers
Chairman of the Board: Karol Bomsztyk, MD. is a Yale trained practicing physician and biotechnology developer. His inventions include ion microsensors, Fast-ChIP and more recently the high throughput Matrix-ChIP. He is a co-inventor of PIXUL®.
CEO and President: Tom Matula, Ph.D. trained as a physicist in his undergrad and graduate studies. As an undergrad at Fresno State University, he helped run the department's Astronomy collection, designing and building a solar flare detector. After graduate school he worked in the field of sonoluminescence trying to understand how a cavitation bubble can get so hot it emits light. That work led to his receiving the DoD Young Scientist and Engineer award and the Presidential Early Career Award.